Summit Global Investments lessened its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 22.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,310 shares of the company’s stock after selling 6,927 shares during the quarter. Summit Global Investments’ holdings […]